Pharmabiz

India–EU FTA to strengthen cancer care by improving access to chemo drugs & advanced medical equipment

Shardul Nautiyal, Mumbai Saturday, January 31, 2026, 08:00 Hrs [IST] ...
Pharmabiz

Health ministry to amend Drugs Rules to change unit of measurement for folic acid

The Union health ministry has issued a draft notification with a proposal to correct the strength of folic acid with regard to its unit of measurement from milligram (mg) to micrograms (mcg), under ...
Pharmabiz

Indian healthcare industry sees facility management as critical component for better patient recovery

Indian healthcare sector is increasingly recognizing facility management as a critical component in improving patient recovery and overall care outcomes. Well-maintained infrastructure, effective ...
Pharmabiz

Health ministry proposes inclusion of analgesic drug pregabalin under Schedule H1

The Union ministry of health and family welfare has issued a draft notification to amend the Drugs Rules, 1945 to include analgesic drug Pregabalin and its drug formulations under the Schedule H1 of ...
Pharmabiz

JPSC to recruit 30 drug inspectors, applications open until February 18

JPSC to recruit 30 drug inspectors, applications open until February 18: Our Bureau, Chennai Saturday, January 31, 2026, 08:00 Hrs [IST] The Jharkhand Public Service Commission (J ...
Pharmabiz

Zydus Hospitals acquires Vadodara Institute of Neurological Sciences Hospital

Zydus Hospitals acquires Vadodara Institute of Neurological Sciences Hospital: Our Bureau, Mumbai Friday, January 30, 2026, 12:15 Hrs [IST] The 300-bed, Zydus Multispecialty and C ...
Pharmabiz

Ascletis reports positive results from phase III open-label study of denifanstat, a first-in-class, once-daily oral FASN inhibitor for acne

Ascletis reports positive results from phase III open-label study of denifanstat, a first-in-class, once-daily oral FASN inhibitor for acne: Hong Kong Friday, January 30, 2026, 16 ...
Pharmabiz

US FDA grants orphan drug designation to Imviva Biotech’s CTD402 for the treatment of T-cell leukaemia and lymphoma

US FDA grants orphan drug designation to Imviva Biotech’s CTD402 for the treatment of T-cell leukaemia and lymphoma: Boston Friday, January 30, 2026, 17:00 Hrs [IST] Imviva Biot ...
Pharmabiz

Mabtech, Sai Life Sciences partner to advance immunology research with EYRA platform at Sai Boston site

Mabtech, Sai Life Sciences partner to advance immunology research with EYRA platform at Sai Boston site: Boston Friday, January 30, 2026, 18:00 Hrs [IST] Mabtech, a global life sc ...
Pharmabiz

ISIC Multispecialty Hospital launches state-of-the-art sports injury clinic

ISIC Multispecialty Hospital launches state-of-the-art sports injury clinic: Our Bureau, Mumbai Friday, January 30, 2026, 17:40 Hrs [IST] ISIC Multispecialty Hospital, renowned fo ...
Pharmabiz

Seamless Therapeutics inks research collaboration with Lilly to develop programmable recombinase-based therapeutics for hearing loss

Seamless Therapeutics inks research collaboration with Lilly to develop programmable recombinase-based therapeutics for hearing loss: Dresden, Germany Friday, January 30, 2026, 15 ...
Pharmabiz

Merck Healthcare R&D India unveils next-gen office in Bengaluru to power global innovation

Merck Healthcare R&D India unveils next-gen office in Bengaluru to power global innovation: Our Bureau, Bengaluru Friday, January 30, 2026, 16:15 Hrs [IST] Merck, a leading scienc ...